Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR35 | Q9HC97 | 2/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | HPGD | P15428 | 2/20 | 0.50 |
| ▸ | TP53 | P04637 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | CRHBP | P24387 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.47 |
| ▸ | CTSB | P07858 | 1/20 | 0.46 |
| ▸ | ITGA4 | P13612 | 3/20 | 0.46 |
| ▸ | ITGB7 | P26010 | 3/20 | 0.46 |
| ▸ | GAA | P10253 | 2/20 | 0.45 |
| ▸ | THRB | P10828 | 1/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | CXCR1 | P25024 | 1/20 | 0.44 |
| ▸ | CXCR2 | P25025 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL8624407 | 0.99 | GPR35 (0.49) | GPR35ALDH1A1HPGDTP53TSHR | |
| Hydrochloric Acid SCHEMBL28959880 | 0.99 | GPR35 (0.49) | GPR35ALDH1A1HPGDTP53TSHR | |
| SCHEMBL27874598 | 0.93 | GPR35 (0.44) | GPR35ALDH1A1HPGDTP53TSHR | |
| SCHEMBL15846971 | 0.82 | HSD17B10 (0.49) | ALDH1A1TP53TSHRMAPK1SMN1; SMN2 | |
| SCHEMBL15846907 | 0.82 | ALDH1A1 (0.49) | ALDH1A1TSHRMAPK1MEN1CRHBP | |
| SCHEMBL9913274 | 0.82 | ALDH1A1 (0.50) | ALDH1A1TSHRMAPK1SMN1; SMN2MEN1 | |
| SCHEMBL18857325 | 0.78 | GPR35 (0.51) | GPR35ALDH1A1HPGDTP53TSHR | |
| SCHEMBL360284 | 0.76 | TSHR (0.56) | GPR35ALDH1A1HPGDTP53TSHR | |
| SCHEMBL13885858 | 0.76 | EGFR (0.42) | ALDH1A1HPGDMEN1KMT2AGAA | |
| SCHEMBL8409393 | 0.76 | ITGA4 (0.53) | GPR35ALDH1A1HPGDTP53TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8889734-B2 | Process for the preparation of dronedarone | SANOFI (FR) | 2014-11-18 | — | — | US | disclosed |
| US-20130261321-A1 | PROCESS FOR THE PREPARATION OF DRONEDARONE | SANOFI (FR) | 2013-10-03 | — | — | US | disclosed |
| US-8501971-B2 | Process for the preparation of dronedarone | SANOFI (FR) | 2013-08-06 | — | — | US | disclosed |
| US-8501971-B2 | Process for the preparation of dronedarone | SANOFI (FR) | 2013-08-06 | — | — | US | disclosed |
| US-20130046103-A1 | PREPARATION OF BENZOFURANS AND USE THEREOF AS SYNTHETIC INTERMEDIATES | MAPI PHARMA LIMITED (IL) | 2013-02-21 | — | — | US | disclosed |
| WO-2012153225-A1 | IMPROVED PROCESSES FOR OBTAINING HIGH PURITY OF DRONEDARONE HYDROCHLORIDE | ALEMBIC PHARMACEUTICALS LIMITED (IN) | 2012-11-15 | — | — | WO | disclosed |
| US-20120289717-A1 | NEW PROCESS FOR THE PREPARATION OF DRONEDARONE | SANOFI (FR) | 2012-11-15 | — | — | US | disclosed |
| US-20120108828-A1 | SYNTHESIS OF DRONEDARONE AND SALTS THEREOF | USV Limited, B.S.D. Marg (IN) | 2012-05-03 | — | — | US | disclosed |
| EP-2144866-A1 | METHOD FOR PREPARING 2-(N-BUTYL)-5-NITROBENZOFURAN | Finorga (FR) | 2010-01-20 | — | — | EP | disclosed |
| WO-2008152217-A2 | PROCESS FOR PREPARING 2-(N-BUTYL)-5-NITROBENZOFURAN | FINORGA (FR) | 2008-12-18 | — | — | WO | disclosed |
| EP-1222181-B1 | METHOD FOR PREPARING A BENZOFURAN OR BENZOTHIOPHENE COMPOUND | RHODIA CHIMIE SA (FR) | 2003-12-10 | — | — | EP | disclosed |
| EP-1222159-A2 | INTERMEDIATES FOR MAKING A BENZOFURAN OR BENZOTHIOPHENE DERIVATIVE NITRATED IN POSITION 5 AND USES THEREOF | RHODIA CHIMIE (FR) | 2002-07-17 | — | — | EP | disclosed |
| EP-1222181-A1 | METHOD FOR PREPARING A BENZOFURAN OR BENZOTHIOPHENE COMPOUND | RHODIA CHIMIE (FR) | 2002-07-17 | — | — | EP | disclosed |
| WO-2001028974-A2 | INTERMEDIATES FOR MAKING A BENZOFURAN OR BENZOTHIOPHENE DERIVATIVE NITRATED IN POSITION 5 AND USES THEREOF | RHODIA CHIMIE (FR) | 2001-04-26 | — | — | WO | disclosed |
| WO-2001029019-A1 | METHOD FOR PREPARING A BENZOFURAN OR BENZOTHIOPHENE COMPOUND | RHODIA CHIMIE (FR) | 2001-04-26 | — | — | WO | disclosed |
| EP-0859776-A1 | COMPOUNDS DERIVED FROM OXAZOLIDIN-2-ONE AND PREPARATION AND THERAPEUTICAL USE THEREOF | SYNTHELABO (FR) | 1998-08-26 | — | — | EP | disclosed |
| EP-0859775-A1 | COMPOUNDS DERIVED FROM 3-(BENZOFURAN-5-YL)OXAZOLIDIN-2-ONE, PREPARATION METHOD THEREFOR AND THERAPEUTICAL USE THEREOF | SYNTHELABO (FR) | 1998-08-26 | — | — | EP | disclosed |
| WO-1997017346-A1 | COMPOUNDS DERIVED FROM 3-(BENZOFURAN-5-YL)OXAZOLIDIN-2-ONE, PREPARATION METHOD THEREFOR AND THERAPEUTICAL USE THEREOF | SYNTHELABO (FR) | 1997-05-15 | — | — | WO | disclosed |
| WO-1997017347-A1 | COMPOUNDS DERIVED FROM OXAZOLIDIN-2-ONE AND PREPARATION AND THERAPEUTICAL USE THEREOF | SYNTHELABO (FR) | 1997-05-15 | — | — | WO | disclosed |
| US-5223510-A | ALKYLAMINOALKYL DERIVATIVES OF BENZOFURAN, BENZOTHIOPHENE, INDOLE AND INDOLIZINE, PROCESS FOR THEIR PREPARATION AND COMPOSITIONS CONTAINING THEM | SANOFI (FR) | 1993-06-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120108828-A1 | SYNTHESIS OF DRONEDARONE AND SALTS THEREOF | CYP3A4, CYP2D6, CYP3A43 | GPR35 4699/4885ALDH1A1 1001/4885HPGD 1453/4885 |
| US-20130046103-A1 | PREPARATION OF BENZOFURANS AND USE THEREOF AS SYNTHETIC INTERMEDIATES | CYP2F1, CYP4F3, CYP2D6 | GPR35 4712/4885ALDH1A1 1830/4885HPGD 2330/4885 |
| US-20120289717-A1 | NEW PROCESS FOR THE PREPARATION OF DRONEDARONE | CYP3A4, CYP4B1, CYP2D6 | GPR35 4409/4885ALDH1A1 803/4885HPGD 1292/4885 |
| US-20130261321-A1 | PROCESS FOR THE PREPARATION OF DRONEDARONE | CYP2D6, CYP3A4, CYP4B1 | GPR35 4561/4885ALDH1A1 842/4885HPGD 1209/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.